From: The usefulness of MMP-9, TIMP-1 and MMP-9/TIMP-1 ratio for diagnosis and assessment of COPD severity
 | COPD (n = 98) | Healthy controls (n = 47) | p |
---|---|---|---|
Age, years, mean ± SDa | 63.4 ± 4.3 | 61.7 ± 4.3 | 0.123 |
Male, n (%)b | 58.2% | 46.8% | Â |
Female, n (%) | 41.8% | 53.2% | 0.199 |
Current smokers, n (%)b | 35 (35.7%) | 14 (29.8%) | 0.489 |
MMP-9 (ng/ml), med (95% CI)c | 848.7 (728.6–981.5) | 58.7 (47.9–76.2) | p ≤ 0.001 |
TIMP 1 (ng/ml), med (95% CI)c | 234.7 (222.5–246.1) | 82.3 (73.0–89.7) | p ≤ 0.001 |
MMP-9/TIMP-1 ratio, med (95% CI)c | 3.4 (2.9–4.2) | 0.40 (0.3–0.5) | p ≤ 0.001 |